EMILY MCGOVERN: Open Payments
NPI 1528578952 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 12 payments from 9 companies in 2025. Trend: 2023 $13 · 2024 $291 · 2025 $380
Food & beverage: $280Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $117 |
| Ferring Pharmaceuticals Inc. | 1 | $91 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Exelixis Inc. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
| PFIZER INC. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: ERLEADA, ADSTILADRIN, PLUVICTO, CABOMETYX, OPDIVO, PADCEV, ORGOVYX, Nubeqa.
Industry payments across MI — which companies pay providers there.
